Modalis Therapeutics Corporation(JP:4883)
Â¥31.00+3.00 (+10.71%)
JP:4883
Modalis Therapeutics Corporation financials statements
Â¥31.00
At close:+3.00 (+10.71%)
Want to see JP:4883 full AI Analyst Report?
Modalis Therapeutics Corporation (4883) Ratios
3 Followers
Modalis Therapeutics Corporation Ratios
JP:4883's free cash flow for Q2 2026 was ¥0.00. For the 2026 fiscal year, JP:4883's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 21.46 | 30.83 | 9.88 | 21.58 | 28.04 |
| Quick Ratio | 21.46 | 30.83 | 9.84 | 21.30 | 27.97 |
| Cash Ratio | 20.86 | 30.47 | 9.51 | 20.68 | 27.31 |
| Solvency Ratio | -12.59 | -9.18 | -3.70 | -13.67 | -1.27 |
| Operating Cash Flow Ratio | -15.71 | -12.21 | -11.38 | -13.37 | -4.14 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | ¥ 2.72B | ¥ 3.47B | ¥ 1.31B | ¥ 2.87B | ¥ 4.55B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.20 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.30 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.06 | 1.04 | 1.47 | 1.06 | 1.09 |
| Debt Service Coverage Ratio | -789.35 | -234.46 | -538.09 | 0.00 | 0.00 |
| Interest Coverage Ratio | -788.80 | -146.02 | -537.08 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.04 | 0.20 | 13.46 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.27 | 1.67 | 0.62 | 1.14 | 7.39 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | -205.37% | 100.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | -6684.03% | -67666.09% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | -6378.66% | -60686.09% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | -5094.31% | -112676.73% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | -6684.03% | -67765.18% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | -6673.36% | -67177.82% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | -6673.36% | -67177.91% |
| Net Income Per EBT | 100.07% | 100.07% | 100.05% | 99.84% | 99.13% |
| EBT Per EBIT | 97.26% | 98.45% | 100.84% | 131.21% | 60.14% |
| Return on Assets (ROA) | -72.62% | -35.70% | -118.06% | -86.35% | -12.18% |
| Return on Equity (ROE) | -77.07% | -37.14% | -173.27% | -91.89% | -13.32% |
| Return on Capital Employed (ROCE) | -78.17% | -37.42% | -129.70% | -69.05% | -21.05% |
| Return on Invested Capital (ROIC) | -78.17% | -37.42% | -129.70% | -68.94% | -20.87% |
| Return on Tangible Assets | -72.62% | -35.70% | -118.06% | -86.35% | -13.78% |
| Earnings Yield | -49.75% | -28.01% | -62.29% | -27.72% | -4.19% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 1.12 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.12 | 3.07 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 3172.15 | -205.96 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 3172.15 | 118.96 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 324.92 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 3172.15 | 118.96 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -27.42 | -31.04 | -72.80 | -65.13 | -26.00 |
| Free Cash Flow Per Share | -27.45 | -31.05 | -74.09 | -71.91 | -29.72 |
| Dividend Paid and CapEx Coverage Ratio | -823.96 | -7617.05 | -56.79 | -9.61 | -6.98 |
| Capital Expenditure Coverage Ratio | -823.96 | -7617.05 | -56.79 | -9.61 | -6.98 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -5.47 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -46.81 | -679.51 |
| Free Cash Flow Yield | -49.01% | -30.44% | -59.75% | -21.47% | -4.85% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.01 | -3.57 | -1.61 | -3.61 | -23.85 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 240.76 | 16023.09 |
| Price-to-Book (P/B) Ratio | 1.55 | 1.33 | 2.78 | 3.32 | 3.18 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.04 | -3.29 | -1.67 | -4.66 | -20.62 |
| Price-to-Operating Cash Flow Ratio | -2.04 | -3.29 | -1.70 | -5.14 | -23.58 |
| Price-to-Earnings Growth (PEG) Ratio | 0.81 | 0.06 | 0.10 | -0.01 | -0.47 |
| Enterprise Value Multiple | -0.68 | -0.53 | -1.00 | -2.64 | -19.01 |
| Enterprise Value | 1.51B | 1.13B | 2.37B | 6.82B | 12.69B |
| EV to EBITDA | -0.68 | -0.53 | -1.00 | -2.64 | -19.01 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 168.34 | 11535.64 |
| EV to Free Cash Flow | -0.71 | -0.79 | -1.03 | -3.26 | -14.85 |
| EV to Operating Cash Flow | -0.72 | -0.79 | -1.05 | -3.60 | -16.98 |
| Tangible Book Value Per Share | 36.15 | 76.92 | 44.58 | 101.05 | 168.48 |
| Shareholders’ Equity Per Share | 36.15 | 76.92 | 44.58 | 101.05 | 193.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | 0.00 | 0.01 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 1.39 | 0.04 |
| Net Income Per Share | -27.86 | -28.57 | -77.24 | -92.85 | -25.70 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.99 |
| Interest Burden | 0.97 | 0.61 | 1.01 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 45.97 | 917.75 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 5.97 | 210.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.27 | 0.00 |
| Income Quality | 0.98 | 1.09 | 0.94 | 0.70 | 1.00 |
Currency in JPY

